Trulieve Cannabis is trading 4.51% up at $12.27, with no clear company-specific catalyst identified for the September 2, 2026 move.
- The company announced planned participation in two September investor conferences, but coverage does not establish that announcement as the cause of the rally.
- Broader U.S. equities are modestly higher.
- Cannabis-sector direction remains unclear.